Tweet
I've been using samtools view -bS on tons of datasets with no problems at all. My workflow is to fastq-dump a .sra file, then clip with fastx-clipper, then map with bowtie, then convert .sam to .bam with samtools view. But this time, the script runs for about 1 minute and then outputs an empty .bam file; w/o any errors. Does anyone have any idea why this is happening? Its odd that it hasn't happened before.
-
-
problem with samtools view -bS
Have you looked at the sam file to see if it looks OK? How did the bowtie alignment go?
How large is the file? -
Header looked fine. Size is ~3gb. Easily converted into interval using galaxy. I've used this workflow dozens of times, this is the first occurrence of empty bam with no error.Comment
-
Should I sortComment
-
I would try to run it on a file you know has worked in the past just to make sure there's a problem with the new file and not something else. If that works, then maybe try running it on the first 1000 lines of your file that isn't working and then you can probably pinpoint if the problem is with a specific read somewhere in the file or the header.Comment
-
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM
Comment